August 22, 2025

PSMA PET/CT and Salvage Radiotherapy in Recurrent Prostate Cancer

Use of prostate-specific membrane antigen (PSMA) PET/CT before undergoing salvage radiotherapy was associated with an improved overall survival and biochemical recurrence–free survival compared those ...

The ASCO Post

August 22, 2025

Kinase Inhibitor Approved for Nonsquamous NSCLC With HER2 TKD–Activating Mutations

The agent was approved by the FDA today for adults with unresectable or metastatic nonsquamous NSCLC whose tumors have HER2 tyrosine kinase domain (TKD)–activating mutations, as detected by an FDA-app...

The ASCO Post

August 15, 2025

Mount Sinai Neurosurgeon Leads Development of First CNS Guidelines for Treating Functioning Pituitary Adenomas

The Congress of Neurological Surgeons (CNS) has released its first comprehensive, evidence-based guidelines for the care of adults with functioning pituitary adenomas (FPAs), a common yet complex condition.

Mount Sinai New York

August 15, 2025

Nivolumab Added to Chemoradiotherapy Reduced Recurrence Risk in High-Risk Head and Neck Cancer

Adding the PD-1 inhibitor nivolumab to standard chemoradiotherapy after surgery significantly reduced recurrence rates for patients with locally advanced head and neck squamous cell carcinoma who are ...

The ASCO Post

August 11, 2025

Which Generative AI Model is the Best Diagnostician?

Comparative evaluation highlights current limitations and potential of LMMs in chest CT diagnostics

The Pathologist

March 12, 2025

As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider

Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment at Mount Sinai’s Cerebrovascular Center. By then, imaging had revealed the aneurysm to be nearly 7 mm in size.

Mount Sinai New York

September 30, 2024

Fox Chase Cancer Center Researchers Show Adaptive Radiation Therapy Delivers Treatment More Effectively in Study Presented at American Society for Radiation Oncology Meeting

Online adaptive radiation therapy (ART) delivered radiation more effectively than conventional radiation therapy in nearly half of patients, while also helping to decrease radiation dose to the esophagus in a majority of patients with thoracic spine tumors. That’s according to the results of a study presented today by Fox Chase Cancer Center researchers at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Washington, D.C.

Fox Chase Cancer Center

June 13, 2025

Weight Loss Drugs Show Promise for Heart Failure

ACC statement highlights semaglutide and tirzepatide as therapies associated with improved symptoms and functional capacity in patients with heart failure with preserved ejection fraction and obesity.

Conexiant

June 27, 2025

Botulinum Toxin and Scopolamine for Radiation-Induced Salivary Gland Toxicity in Metastatic Prostate Cancer

Injection with botulinum toxin type A plus transdermal scopolamine led to the reduction in radiation-induced salivary gland toxicity without compromising PSMA tumor uptake in patients with metastatic ...

The ASCO Post